Key expectations for long-term treatment include: Weight loss velocity decreases over time, with most reduction occurring in the first 912 months Plateaus lasting 48 weeks are common and do not indicate treatment failure Individual response varies based on genetics, baseline metabolic health, adherence, and lifestyle factors Continued medication use is typically necessary to maintain weight loss Non-scale victoriesimproved mobility, reduced medication burden for comorbidities, better quality of lifeare equally important outcomes Patients should also be aware of potential adverse effects that may affect long-term adherence
Tirzepatide occupies a unique place in modern peptide pharmacology: it is the first commercially synthesized dual agonist targeting both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor
Let Be You Medical Help If youve been feeling stuck, frustrated, or unsure if Semaglutide is still working for you, youre not alone
The body needs time to adjust to the new metabolic signals oral semaglutide provides
General Strategies Stress Management: Practices such as exercise, yoga, and meditation can help reduce stress levels
